P. Robins

Publications119
h-index21
Citations2,398
Highly Influential Citations73
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • J. Sosman
  • 569 Publications, 78,220 Citations
  • J. Wolchok
  • 667 Publications, 91,183 Citations
  • A. Geller
  • 314 Publications, 10,185 Citations
  • T. Johnson
  • 285 Publications, 16,501 Citations
  • Publications
  • Influence
Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours
Sporadic basal cell carcinoma (BCC) is the most common type of malignant cancer in fair-skinned adults. Familial BCCs and a fraction of sporadic BCCs have lost the function of Patched (Ptc), a Sonic… Expand
  • 628
  • 29
Mohs micrographic surgery.
  • P. Robins
  • Medicine
  • The Journal of dermatologic surgery and oncology
  • 1 March 1993
  • 210
  • 12
Microcystic adnexal carcinoma: collaborative series review and update.
BACKGROUND Microcystic adnexal carcinoma (MAC) is a malignant appendageal tumor first described in 1982. It can be clinically and histologically confused with other malignant and benign cutaneous… Expand
  • 166
  • 9
  • PDF
Mohs surgery for periocular basal cell carcinomas.
Cure rates for 631 periocular basal cell carcinomas treated by Mohs surgery proved to be 98.1% for primary lesions and 93.6% for previously treated lesions. All recurrences of primary lesions… Expand
  • 49
  • 4
Mohs Micrographic Surgery for Dermatofibrosarcoma Protuberans: University of Miami and NYU Experience
BACKGROUNDDermatofibrosarcoma protuberans (DFSP) is a relatively rare cutaneous malignancy with the potential for significant local destruction and morbidity. This neoplasm has a tendency for… Expand
  • 91
  • 3
Risk factors for local recurrence of primary cutaneous squamous cell carcinomas. Treatment by microscopically controlled excision.
Four hundred fourteen primary cutaneous squamous cell carcinomas were treated by microscopically controlled excision. A five-year mortality-table adjusted cure rate of 93.3% was achieved. The… Expand
  • 71
  • 2
Basal-cell carcinomas on covered or unusual sites of the body.
Basal-cell carcinomas on covered, anatomically shielded, or otherwise unusual sites of the body are rare compared to the number on constantly exposed parts of the body, but since basal-cell… Expand
  • 65
  • 2
Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score.
Despite the high cure rate achieved for basal-cell carcinomas treated with microscopically controlled excision, recurrences do occur. To determine if lesions that are likely to recur may be predicted… Expand
  • 53
  • 2
The use of photodynamic therapy in dermatology: results of a consensus conference.
Photodynamic therapy (PDT) has significant promise in improving outcomes of patients with a variety of cutaneous conditions. A group of experts met to review the principles, indications, and clinical… Expand
  • 124
  • 2
  • PDF
P53 oncoprotein expression and gene mutations in some keratoacanthomas.
OBJECTIVE To analyze the relationship of p53 oncoprotein overexpression in most keratoacanthomas (KAs) with gene mutations. DESIGN Expression of p53 oncoprotein in immunohistochemical staining and… Expand
  • 24
  • 2